Summit Therapeutics, Inc. · 8 hours ago
Director, Value Outcomes Liaison
Summit Therapeutics, Inc. is a biopharmaceutical oncology company dedicated to improving the quality of life for patients with serious unmet medical needs. They are seeking a Director, Value Outcomes Liaison, responsible for engaging with US population-based decision makers to educate them on the clinical and economic impacts of Ivonescimab, thereby facilitating access and improving patient outcomes.
Responsibilities
Independently cultivate and manage relationships with PBDMs, acting as primary point of contact and collaborating closely with other field roles to ensure an aligned approach to stakeholder engagement
Collaborate with internal HEOR team and market access team, to execute on scientific engagement strategy for appropriate stakeholders (e.g., Payers, PBMs, GPOs, IDNs and Oncology Pathways) within a territory or customer base
Serve as a conduit and resource for providing clinical and healthcare economic information (HCEI) to payers and formulary decision-makers
Maintaining required knowledge of ivonescimab, to proactively and reactively communicate clinical and economic information related to ivonescimab to advance formulary decision-making and improve patient outcomes
Capture and communicate internally key stakeholder insights and evidence gaps/needs including potential opportunities for collaboration
Understand the medical affairs priorities to contribute to content strategy development and execute aligned field tactics
Work with stakeholders to ensure inclusion of ivonescimab in clinical/payer pathways, and treatment order sets, while optimizing budget assessments
Collaborate effectively with medical affairs, HEOR, market access and other colleagues as appropriate in support of developing and implementing account engagement plan, providing input on scientific and value topics
Understanding of principles of study design, methodology, data analysis, and interpretation to successfully communicate data to stakeholders
Utilize and effectively present clinical, humanistic, and economic evidence as well as the value proposition in a clear and compelling manner to the payer audience
Maintain understanding of market and payer needs in an increasingly complex and dynamic environment to drive actionable recommendations to inform medical and market access strategy
All other duties as assigned
Qualification
Required
MD, PharmD, or PhD in Health Services Research, Health Economics, or related field
Minimum of 12+ years relevant experience in healthcare industry with minimum 5+ years direct experience in the pharmaceutical, managed care, or consulting industries
Previous experience in Oncology, preferably non-small cell lung cancer (NSCLC)
Previous experience in field-based role with strong understanding of the US healthcare system, market access landscape and value-based decision makers
Experience analyzing health care data and utilizing real-world evidence (RWE) is a plus
Strong analytical capabilities and excellent communication skills, including ability to communicate large amounts of scientific information in a manner that is clear, concise and memorable
Ability to work collaboratively across diverse teams and manage multiple stakeholders with ability to influence and collaborate to make a business impact
Ability to be proactive, enthusiastic and goal oriented
Travel up to approximately 75% of time, including overnight travel for internal and external meetings
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
H1B Sponsorship
Summit Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (6)
2023 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.79BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2025-10-21Post Ipo Equity· $500M
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
Recent News
The Motley Fool
2026-01-13
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase